Strategies to suppress aggregation of recombinant keratinocyte growth factor during liquid formulation development

B L Chen1, T Arakawa, E Hsu

  • 1Department of Pharmaceutics and Drug Delivery, Amgen Inc., Thousand Oaks, CA 91320.

Related Concept Videos